Progress, but not yet ready for clinical use: interrupting immune-mediated destruction of pancreatic beta cells in type 1 diabetes.
Diabetes Clinical Research, Benaroya Research Institute, Seattle, WA 98105, USA. cjgreen@benaroyaresearch.org
Carla J
CJ
Greenbaum